The researchers extracted adult human fat cells and injected them with compound 5-Azacytidine and platelet-derived growth factor-AB.
Here are four insights:
1. The researchers implanted the induced multipotent stem cells on damaged tissue in mice to see if they would grow and heal tissue.
2. The experiments have proved successful.
3. The researchers expect to conduct human trials by late 2017, and believe the iMS cells could help patients with spinal cord injuries.
4. Further studies are needed to determine whether iMS cells stay dormant or react when needed.
More articles on spine:
DISC Sports & Spine Center: 5 ways to avoid injuries when returning to exercise
Dr. Neal Kassell named to NCI’s Blue Ribbon Panel for cancer moonshot initiative: 4 notes
How cervical disc arthroplasty can impact patient depression — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
